Dural Venous Sinus Stent in Idiopathic Intracranial Hypertension
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorAssiut University
About this trial
This study aims to identify clinical determinants and factors that predict outcome including primary outcome and secondary outcome depending on factors in individual patients with Idiopathic intracranial hypertension treated by Dural venous sinus stenting.
Eligibility criteria
Qualifiers
40 Patients of idiopathic intracranial hypertension subjected to Dural venous sinus stenting met the modified Dandy criteria for (IIH).
Signs and symptoms of increased intracranial pressure: Headaches, nausea, vomiting, visual changes, and papilledema.
No localizing or focal neurologic signs: Except for possible unilateral or bilateral VI nerve paresis.
Elevated cerebrospinal fluid (CSF) pressure: Without cytologic or chemical abnormalities.
Disqualifiers
Age less than or equal to 18 years.
severe allergic reaction to iodine contrast or chronic Kidney disease.
contraindication to general anesthesia or antiplatelet anticoagulants, Hemorrhagic Diathesis
patients with secondary causes of intracranial hypertension: Dural arteriovenous fistula or other arteriovenous lesion affecting cortical venous flow.
Trial design
Treatments tested in this trial
- Dural venous sinus stenting
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov